1 of 3 listed pharmas spends 40% of their sales into SG&A

August 21, 2017 Posted by Yakup

It was observed 1 of 3 listed pharmaceutical companies had a SG&A(selling, general and administrative) expense/sales ratio more than 40%. The ratio that is higher than other industries has worked as an obstacle of increasing profitability. Yakup Shinmoon(www.yakup.com) analyzed 60 KOSPI and ...

Kuhnil Pharm acquires approval of Omega-3/rosuvastatin combination drug for first time in the world

August 21, 2017 / Posted by Yakup

Kuhnil Pharm(CEO Young-Joong Kim) announced approval of Rosumega SC(generic name: omega-3-acids ethyl esters 90 + rosuvastatin) from the Ministry of Food and Drug Safety on the 31st of July. Rosum...

Who will become candidates for next KPDA chairman?

August 21, 2017/ Posted by Yakup

2 months ahead of election of the Korea Pharmaceutical Distribution Association(KPDA) chairman, there has been a lot of rumors about candidates for the next chairman. According to the industry, ca...

Pharmaceutical and distribution companies tense over change of wholesaler for 5 Paik Hospitals

August 21, 2017/ Posted by Yakup

Over the medicine supply to Inje University Paik Hospitals, it has been noisy in the pharmaceutical and distribution industries. This is because distributors supplying medicines to the Inje Univers...

Trendy ‘targeted therapy’ working on ulcerative colitis treatment too

August 21, 2017/ Posted by Yakup

‘Targeting’ has been a trend in the new drug development market for the past several years. New drugs had been developed with a mechanism of affecting the entire body, but the new drug ...

TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.